In our study, in PD patients with NFE2L2 variants (117E and 141H), we observed the effects of the NFE2L2 variants on its downstream gene expression including GSTM1 and SOD1, a major antioxidant enzyme in Parkinsonism. This evidence concerns the gene GSTM1 and Parkinson disease.